COVID-19 is no longer a global health emergency, but it hasn’t disappeared. The World Health Organization officially ended its Public Health Emergency of International Concern designation on May 5, 2023, marking the formal end of the pandemic phase. The virus still circulates, people still get infected, and updated vaccines are still recommended, but the scale and severity of the crisis have fundamentally changed.
What “Over” Actually Means
When WHO Director-General Tedros Adhanom Ghebreyesus made the announcement in May 2023, he was careful with his words: “I declare COVID-19 over as a global health emergency.” That distinction matters. The emergency is over. The virus is not gone. Countries were told to transition from emergency mode to managing COVID-19 alongside other infectious diseases, the way we manage flu, RSV, and other respiratory illnesses that circulate year after year.
Epidemiologists describe this shift as the move from a pandemic to an endemic disease. In practical terms, endemic means the virus persists in the population at a roughly steady, predictable level from year to year, with seasonal surges that healthcare systems can absorb without crisis-level strain. COVID-19 is now largely behaving this way in most parts of the world, though it hasn’t settled into as clean a seasonal pattern as influenza.
The Virus Is Still Circulating
SARS-CoV-2 continues to evolve and spread. As of April 2026, the CDC tracks more than a dozen distinct viral lineages circulating in the United States. The XFG family of variants currently dominates, with XFG.1.1 alone accounting for roughly 32% of sequenced cases. Several other lineages, including PQ and NB subvariants, make up smaller shares. This constant churn of new variants is normal for an endemic respiratory virus and is one reason updated vaccines are released on a regular schedule.
Wastewater surveillance, one of the most reliable tools for tracking community spread, shows COVID-19 viral activity at “very low” levels nationally as of mid-April 2026. That doesn’t mean zero transmission. It means the amount of virus detected in sewage systems, a proxy for how many people are actively infected, is at the lowest end of the scale. These levels fluctuate seasonally, typically rising in winter months.
Long COVID Remains a Concern
One of the reasons public health experts resist saying COVID is simply “over” is long COVID. A large meta-analysis covering 144 studies estimated that about 36% of people who contract COVID-19 develop symptoms lasting weeks or months beyond the initial infection. In U.S.-specific studies, the estimate is closer to 29%. These figures span the full pandemic era and include infections from earlier, more severe variants, so the risk from current strains in vaccinated people is likely lower, though not zero.
What’s particularly notable is that long COVID symptoms don’t always resolve quickly. The same analysis found that prevalence was actually higher, around 46%, when researchers followed patients for one to two years after infection compared to shorter follow-up periods. Common lingering symptoms include fatigue, brain fog, shortness of breath, and sleep problems. For most people, these eventually improve. For a smaller subset, they persist and significantly affect daily life. This ongoing burden is part of why COVID-19 still gets more public health attention than a typical cold virus.
Vaccines and Treatment in 2025-2026
COVID-19 vaccination now follows a pattern similar to the annual flu shot. The CDC’s 2025-2026 guidance recommends one updated dose for healthy adults aged 12 to 64 who have been previously vaccinated. Adults 65 and older are recommended to get two doses of the updated vaccine, spaced about six months apart, reflecting the greater risk severe illness poses to older adults. You should wait at least eight weeks after your last COVID vaccine dose before getting the new one.
Antiviral treatment also remains available. Paxlovid, the most widely prescribed oral antiviral for COVID-19, reduces the risk of hospitalization by about 39% and the risk of death by 61%, based on real-world data covering the Omicron era. It’s most beneficial for older adults and those at higher risk of severe outcomes. The drug works best when started within the first few days of symptoms, so getting tested promptly still matters if you’re in a higher-risk group.
What This Means for Daily Life
For most people, day-to-day life has fully returned to pre-pandemic norms. Mask mandates, capacity limits, and routine testing requirements are gone in nearly all settings. Schools, workplaces, and travel operate without COVID-specific restrictions. When people catch COVID now, the experience for the majority is similar to a bad cold or flu: unpleasant for several days, then recovery at home.
The practical takeaway is straightforward. The pandemic, defined as a global health crisis requiring emergency measures, is over. COVID-19 itself is not over in the sense of being eradicated. It’s a permanent part of the respiratory virus landscape, sitting alongside flu and RSV as something that circulates every year, causes seasonal waves, and poses the greatest risk to older adults and people with weakened immune systems. Staying up to date on your annual vaccine, knowing that effective treatments exist if you’re at high risk, and recognizing that infection is still possible are the basics of living with an endemic virus rather than fighting a pandemic.